Skip to main content
. Author manuscript; available in PMC: 2011 Jan 3.
Published in final edited form as: J Drug Deliv Sci Technol. 2010 May;20(3):163–169. doi: 10.1016/s1773-2247(10)50025-x

Figure 5.

Figure 5

Post-translational protein deactivation using chemical inducers of dimerization. A rapamycin-analogue (FK1012-A) approach is depicted. A) In the presence of FK1012-A, FK506-binding protein (FKBP) forms dimeric complexes, which inhibits the activity of some proteins. B) In the absence of FK1012-A, FKBP becomes monomeric, which restores protein activity.